Predictive Factors for the Efficacy of CD19 CAR-T Therapy in Relapsed/Refractory Large B-Cell Lymphoma: A Clinical Study

Clinical trial NCT07236203 · RECRUITING

Trial details

NCT number: NCT07236203
Sponsor: Fudan University
Status: RECRUITING
Study type: OBSERVATIONAL

Large B-Cell Lymphoma

Start date: 2024-02-29
Primary completion: 2026-08-30
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.